The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Abstract
Objective: Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited effective treatment options. An alternative strategy is to target cells, such as tumour-infiltrating macrophages, in the HCC tumour microenvironment. The CCL2/CCR2 axis is required for recruitment of monocytes/macrophages and is implicated in various aspects of liver pathology, including HCC. We investigated the feasibility of CCL2/CCR2 as a therapeutic target against HCC. Design: CCL2 expression was analysed in two independent HCC cohorts. Growth of three murine HCC cells was evaluated in an orthotopic model, a postsurgical recurrence model and a subcutaneous model in mice after blocking CCL2/CCR2 axis by a novel CCR2 antagonist or knocking out of host CCR2. In vivo macrophage or T cell depletion and in vitro cell coculture were further conducted to investigate CCL2/CCR2-mediated crosstalk between tumour-associated macrophages (TAMs) and tumour cells. Result: CCL2 is overexpressed in human liver cancers and is prognostic for patients with HCC. Blockade of CCL2/CCR2 signalling with knockout of CCR2 or with a CCR2 antagonist inhibits malignant growth and metastasis, reduces postsurgical recurrence, and enhances survival. Further, therapeutic blocking of the CCL2/CCR2 axis inhibits the recruitment of inflammatory monocytes, infiltration and M2-polarisation of TAMs, resulting in reversal of the immunosuppression status of the tumour microenvironment and activation of an antitumorous CD8 + T cell response. Conclusions: In patients with liver cancer, CCL2 is highly expressed and is a prognostic factor. Blockade of CCL2/CCR2 signalling suppresses murine liver tumour growth via activating T cell antitumour immune response. The results demonstrate the translational potential of CCL2/CCR2 blockade for treatment of HCCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Self-citationTherapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839
Functional role of chemokines in liver disease models
Sahin, H., Trautwein, C., & Wasmuth, H. E. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.168 · Cited by 107
Research works printed but not linked: 40
- 10.3322/caac.20107 · DOI · Paper page
- Ryder, 2003, Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults, Gut, 52, iii1
- 10.1038/nrc1782 · DOI · Paper page
- 10.1126/science.1232227 · DOI · Paper page
- 10.1016/j.cell.2010.03.014 · DOI · Paper page
- 10.1007/s00595-011-0058-8 · DOI · Paper page
- 10.1016/j.humpath.2008.08.011 · DOI · Paper page
- 10.1016/j.coi.2010.01.009 · DOI · Paper page
- 10.1159/000012021 · DOI · Paper page
- 10.1002/emmm.201202367 · DOI · Paper page
- 10.1126/science.1178331 · DOI · Paper page
- 10.1038/ni1309 · DOI · Paper page
- 10.1038/nrc3078 · DOI · Paper page
- 10.1002/hep.24599 · DOI · Paper page
- 10.1136/gutjnl-2011-300304 · DOI · Paper page
- 10.4049/jimmunol.1302821 · DOI · Paper page
- 10.1016/B978-0-12-385071-3.00003-4 · DOI
- 10.1093/jnci/djq044 · DOI · Paper page
- 10.1007/s10637-012-9869-8 · DOI · Paper page
- 10.1093/jnci/64.4.809 · DOI
- 10.1371/journal.pone.0028405 · DOI
- 10.1038/nrd2734 · DOI · Paper page
- 10.1097/01.sla.0000197706.21803.a1 · DOI · Paper page
- 10.1038/nrc1256 · DOI · Paper page
- 10.1007/s12307-011-0091-6 · DOI
- Mizgerd, 1996, Gadolinium induces macrophage apoptosis, J Leukoc Biol, 59, 189, 10.1002/jlb.59.2.189 · DOI
- 10.1002/hep.510290324 · doi:10.1002/hep.510290324
- 10.1016/j.it.2011.12.001 · DOI · Paper page
- 10.1002/hep.23711 · DOI
- 10.1038/nrgastro.2010.221 · doi:10.1038/nrgastro.2010.221
- 10.2174/157488708783330549 · DOI
- 10.1200/JCO.2013.49.5622 · doi:10.1200/jco.2013.49.5622
- 10.4049/jimmunol.0802793 · DOI
- 10.1158/0008-5472.CAN-11-1792 · DOI · Paper page
- 10.1126/science.aaa8172 · DOI · Paper page
- 10.1016/j.jhep.2013.06.008 · DOI
- Capece, 2013, The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages, Biomed Res Int, 2013, 187204, 10.1155/2013/187204 · DOI · Paper page
- 10.1111/imm.12023 · DOI · Paper page
- 10.1038/nature13862 · DOI · Paper page
- 10.1038/nrgastro.2010.100 · DOI · Paper page
Cited by
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Targeting tumor-associated macrophages in cancer
Pathria, P., Louis, T. L., & Varner, J. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.003 · Cited by 933
Metadata
- Authors
- Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., & Wang, H.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-10-09
- Volume
- 66
- Issue
- 1
- Pages
- 157-167
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2098236252
- Cited by
- 737
- References
- 7
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. https://app.cochat.ai/papers/10.1136/gutjnl-2015-310514
- The paper
- Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., & Wang, H. (2017). Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. https://doi.org/10.1136/gutjnl-2015-310514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.